May 16, 2023

Satori Capital Raises $10.3M for Satori Neuro Fund, Following Launch of Mental Health Venture The funding builds on the Dallas-based investment firm's launch of Satori Neuro in February. Managing Partner and Chief Investment Officer Dr. Amy Kruse will identify and seize opportunities that address “the world’s most critical mental health challenges." Amy Kruse is general partner and chief investment officer at Satori Neuro. [Photo: Satori Capital] Dallas-based private equity firm Satori Capital is making headway in its mission to foster positive change in the mental health sector. The firm has secured $10.26 million for its latest fund, “Satori Neuro Partners LP,” according to a federal filing. The investment firm, co-founded by Sunny Vanderbeck and Randy Eisenman, has a good start on its plans to raise a total of $25 million for the fund, with the recent raise being a significant milestone. Satori Capital aims to prove that purpose-driven initiatives can drive business success while making a positive impact. Funding “businesses that elevate humanity” In February, Dallas Innovates reported Satori’s launch of mental health investment firm Satori Neuro . The firm said the new business aligns with Satori’s mission to create, fund, and inspire “businesses that elevate humanity.” The new venture, led by Managing Partner and Chief Investment Officer Dr. Amy Kruse, will seek opportunities in innovative therapeutics, including psychedelic medicine, brainwave devices, VR and AR protocols, and more. Kruse’s mandate at Satori Neuro is to identify and seize opportunities that address “the world’s most critical mental health challenges,” the firm said. Kruse, a former GP at a VC firm investing in early-stage scientific-driven startups, has over 20 years of expertise in science, technology, and innovation, including the defense arena. Kruse’s expertise gives Satori “a distinct advantage in recognizing the most promising and innovative businesses in the sector,” Co-founder Eiseman said at the time. Translating knowledge to real-world innovation Kruse says it’s a “thrilling time for neuroscience and brain health, adding that our knowledge is “rapidly transforming into real-world applications” that can reinvent our approach to mental health challenges. “I think of these innovations as the future of human flourishing,” Kruse said, looking forward to supporting companies developing breakthrough treatments and new business models. Beyond its mental health initiative, Satori Capital has a string of recent successes, popping up on numerous rankings. Last year, the firm garnered recognition as a top-ranking workplace on several prestigious lists, including the Pensions & Investments’ “Best Places to Work in Money Management,” Texas Association of Business’ “Best Companies to Work for in Texas,” and its seventh Fort Worth Inc. ‘Best Companies’ yards. The firm was also honored with a place on Inc. magazine’s “ Founder-Friendly Investors ” list for the second consecutive year. Firm focus Satori Capital focuses on consumer products with e-commerce potential, IP- or engineering-driven manufacturing, commercial and industrial services, and health and wellness sectors. Their investment criteria include majority investments in businesses with EBITDA of $5 to 35 million and minority investments in businesses with EBITDA of $10 to 50 million, per its website. The firm targets investments to talented leadership teams, primarily in the U.S., that embody the principles of conscious capitalism and want to accelerate their companies’ growth trajectories, it said. Get on the list. Dallas Innovates, every day. Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day. One quick signup, and you’re done. The new venture will be led by Managing Partner and Chief Investment Officer Dr. Amy Kruse. It will seek opportunities in innovative therapeutics including psychedelic medicine, brainwave devices, VR and AR protocols, and more. “We've learned more about the human brain in the last five years than we previously learned in the last 50—and that knowledge is rapidly transforming into real-world applications," Kruse says. Dunnu Devulapally has faced his own struggles with identity issues as a first-generation American as well as with substance abuse. Now he aims to help people facing these and other mental health-related issues by launching NRVE, a Dallas-based research nonprofit. Targeting younger generations, NRVE will focus on awareness in youth, support for veterans, support for homeless people, and research for substance abuse, domestic violence, and suicide prevention. With the information it collects, NRVE plans to become the “Google” for the mental health space, Devulapally told Dallas Innovates. In this week’s roundup of hires, promotions, and accolades in North Texas, you’ll also find news from Integrity Marketing, Tauro Capital Advisors, Draper Richards Kaplan Foundation, Ashton Woods, Cariloop, EisnerAmper, Mosaic, Gore Range Capital, One Day, and others. You'll also find CDFI Friendly Fort Worth's first board appointments, Texas Women's Foundation's newest board members, and North Central Texas Council of Government's new president. The American Heart Association is looking to emerging technology to help in its fight against one of the leading global causes of death—cardiovascular disease.The Dallas-based organization, alongside global health tech giant Philips, announced re-upping their investment in VC fund Cardiation Capital. Plus, bidding war looms for Dallas-based Signify Health; Fort Worth-based Harvest Returns raises $780K for new fund; Dallas property consulting firm Masterplan is acquired by New York company; Washington D.C. PE firm adds to its Fort Worth architectural platform; Pharos Capital sells stake in diagnostic testing company; and more North Texas deals. TAGS: